Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 14 Nov 2025 for ARS Pharmaceuticals, Inc.. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Pratik Shah: trading record in brief
This profile gathers the share dealings of Pratik Shah in ARS Pharmaceuticals, Inc. Between 8 November 2022 and 12 November 2025, the trades on record add up to 6 filings.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
Most recently, on 14 November 2025, the filings show a transaction in ARS Pharmaceuticals, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Pratik Shah
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations6 total
250,000 shares0Common StockSEC:0001580787-25-000004:0
200,000 shares0Common StockSEC:0001415889-24-017260:0
1,332,950 shares0Common StockSEC:0001415889-24-016095:0
2,665,800 sharesCommon StockSEC:0001415889-24-016094:0
2,665,800 sharesCommon StockSEC:0001415889-24-015769:0
10,156,204 sharesCommon StockSEC:0001209191-22-056445:0
6 of 6 declarations
